Strategic footprint Strong national network with 50 labs and 500+ collection centers presents multiple cross-selling opportunities to hospitals, clinics, and research entities seeking integrated diagnostic services across regions.

Genomic leadership Leading edge molecular and genomic testing capability enables offering advanced diagnostic panels to oncology customers, labs, and research partners looking for comprehensive cancer profiling and second opinion services.

Growth engines Recent expansions in Delhi and Maharashtra, plus collaboration with Nasik Specialty Laboratory, indicate momentum in regional capacity building that can be leveraged to upsell new test menus and faster service offerings.

Experienced team A highly skilled team with extensive experience across diagnostics enhances credibility for enterprise partnerships, contract-based testing, and international referrals in neighboring markets.

Resilient operations Pandemic-era reliability and patient-centered logistics capabilities position Oncquest as a trusted partner for healthcare networks seeking dependable, end-to-end diagnostic support and crisis-responsive service.